NOX 2.86% 7.2¢ noxopharm limited

Bristol Myers Squibb must be providing Opdivo for the IONIC...

  1. RBx
    643 Posts.
    lightbulb Created with Sketch. 1002
    Bristol Myers Squibb must be providing Opdivo for the IONIC trial, at no cost, so they are sure to watch this trial with great interest.

    We now have BMS as a potential checkpoint-inhibitor partner, Novartis for Lutetium PSMA, and every large pharma for Septic Shock and boring old Cancer.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.